Stay updated on Nivolumab + HF10 for Resectable Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + HF10 for Resectable Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + HF10 for Resectable Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-20T19:36:23.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Added related topics Melanoma and MedlinePlus Genetics. Updated site revision from v3.4.2 to v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-06T18:15:43.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Removed the Melanoma label and the related topics: MedlinePlus Genetics from the page.
    Difference
    0.2%
    Check dated 2026-02-27T18:59:02.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Minor metadata updates: the page now shows a new revision label (v3.4.2) and adds the Melanoma keyword along with related topics such as MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-13T12:36:25.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision updated to v3.4.1. Melanoma and related topics (MedlinePlus Genetics) were removed, and the reference to Revision: v3.4.0 was deleted.
    Difference
    0.2%
    Check dated 2026-02-05T13:43:39.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now lists Melanoma as a topic and adds a related topics link to MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-22T06:24:36.000Z thumbnail image

Stay in the know with updates to Nivolumab + HF10 for Resectable Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + HF10 for Resectable Melanoma Clinical Trial page.